DPT Meeting: Panel 1 – Protocol Objectives & Eligibility PANEL Discussion 1: Protocol Objectives and Eligibility Moderators: Abby Bronson, Scott Berry Panelists: Joanne Donovan, MD, PhD, Catabasis Pharmaceuticals Michael Panzara, MD, MPH, Wave Life Sciences Hank Mayer, MD, Children’s Hospital of Philadelphia Paula Clemens, MD, University of Pittsburgh Gretchen Egner, Parent/Advocate 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 5 years ago You may also like 1:07:15 DPT Meeting: Panel 2 – Endpoints & Schedule of Events 5 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 44:50 DPT Meeting: Panel 3 – Operations & Governance 5 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 1:02:36 DPT Meeting: Parent Commentary & Advocacy Perspective 5 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 18:59 DPT Meeting: Key Takeaways & Next Steps 5 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 1:22:00 Understanding Duchenne From The Start 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings 1:09:37 Understanding Duchenne Behavioral Challenges (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings 19:21 Where Have We Come From & Where are We Going? (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings 1:31:49 The Complexities of Duchenne (PPMD 2019 Conference) 5 years ago 2019 PPMD Annual Conference,Conferences & Meetings «1…2122232425»Page 23 of 25
by: Parent Project Muscular Dystrophy
